Chinese medicine injection liquid for treating cerebro-cardio vascular disease and diabetes
A cardiovascular and cerebrovascular disease, injection technology, applied in cardiovascular system diseases, metabolic diseases, drug delivery and other directions, can solve the problems of reducing bioavailability, poor medication compliance, etc., to improve medication compliance, save the absorption process, The effect of improving bioavailability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
example 1
[0015] First select the raw materials of Salvia miltiorrhiza, Chuanxiong and Pueraria lobata, and use the general extraction method to extract the active ingredients in Salvia miltiorrhiza, Chuanxiong and Pueraria lobata respectively; The main ingredients, and add appropriate amount of common pharmaceutical excipients to make intravenous injections, which can be small needles or powder injections. Compared with oral preparations with similar medicinal ingredients, the treatment time is shortened by 25%.
example 2
[0017] Take 100 grams of Danshen extract, 70 grams of Chuanxiong extract, and 140 grams of Pueraria root extract and mix them as the main ingredients, then add 80 grams of Astragalus extract, and add an appropriate amount of general pharmaceutical excipients to make an intravenous injection. Small needles or powder injections. Compared with oral preparations with similar medicinal ingredients, the treatment time is shortened by about 25-40%.
example 3
[0019] Take 100 grams of Salvia miltiorrhiza extract, 100 grams of Chuanxiong extract, and 100 grams of Pueraria root extract and mix them as the main ingredients, then add 35 grams of licorice extract, 50 grams of safflower extract, and add appropriate amount of common medicinal excipients. Made into intravenous injection, it can be small needle or powder injection. Compared with oral preparations with similar medicinal ingredients, the treatment time is shortened by 30%.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More